Background
}There is a
higher prevalence of hepatitis C virus (HCV) infection in patients with end-stage renal
disease (ESRD) than in
the general population1
}Patients
with ESRD and chronic hepatitis C are at an increased risk of disease progression and decreased
graft survival after transplantation
}Eradication
of HCV can increase eligibility for kidney transplantation and improve outcomes
}Thus,
effective treatment for chronic hepatitis C in patients with ESRD is urgently needed
1. Dienstag JL, McHutchison JG.
Gastroenterology 2006; 130: 231